Issuu on Google+

Ocular Disorders: Rising Therapeutics, Technologies, and Devices

Published: December 2013 Single User PDF: US$ 1995 Corporate User PDF: US$ 9550

Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.

Š ReportsnReports.com / Contact sales@reportsandreports.com

1


Ocular Disorders: Rising Therapeutics, Technologies, and Devices New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers a handful of companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while alsoproviding alternative therapeutic options for various ocular complications. In an interview with several companies including Oraya Therapeutics, VisionCare Ophthalmic Technologies, Omeros, and Kala Pharmaceuticals, representatives mentioned several technologies and devices in development to improve the current line of therapeutics. Both invasive and noninvasive procedures are discussed, along with current treatment options and how they relate to rising therapies. These techniques include: Radiation therapy Implantable telescope technology PharmacoSurgery Mucosal penetrating products Also available are complementary interviews with company representatives at the end of each section. Inquire for DISCOUNT@ http://www.reportsnreports.com/contacts/discount.aspx?name=274702 . Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

2


Ocular Disorders: Rising Therapeutics, Technologies, and Devices The interviewees include: President and CEO of Oraya Therapeutics Marketing Director of VisionCare Ophthalmic Technologies Chairman and CEO of Omeros CMO of Kala Pharmaceuticals Also included in this report is a demographic survey of researchers working in ocular disorders. Some of the concepts include ocular areas of research, promising therapeutic options, targets of interest, and challenges encountered. Complete report available @ http://www.reportsnreports.com/reports/274702-ocular-disordersrising-therapeutics-technologies-and-devices.html .

Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

3


Ocular Disorders: Rising Therapeutics, Technologies, and Devices Table of Contents Executive Summary Chapter 1:Age-Related Macular Degeneration Wet AMD Dry AMD Chapter 2:Therapeutic Efficacy Anti-VEGF therapies Pegaptanib Bevacizumab Ranibizumab Chapter 3:Oraya Therapeutics Radiotherapy platform Automatic Positioning System (APS) I-Guide System software Radiation dosing

Inquire for DISCOUNT@ http://www.reportsnreports.com/contacts/discount.aspx?name=274702 . Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Š ReportsnReports.com / Contact sales@reportsandreports.com

4


Ocular Disorders: Rising Therapeutics, Technologies, and Devices Chapter 4:VisionCare Ophthalmic Technologies Company background Telescope technology Complications and challenges Interview with Reena Mishra Company background Telescope technology Competitive advantage Complications and challenges Chapter 5:Omeros Company background PharmacoSurgery platform Pipeline Competitive advantage Challenges encountered Complete report available @ http://www.reportsnreports.com/reports/274702-ocular-disordersrising-therapeutics-technologies-and-devices.html . Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Š ReportsnReports.com / Contact sales@reportsandreports.com

5


Growth & Challenges in Ocular Disorder Industry